Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

1.360 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hoth Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Keep an eye on the top gainers and losers in Wednesday's session. ↗

May 27, 2026

Via Chartmill

Most active stocks in Wednesday's session ↗

May 27, 2026

Via Chartmill

Wednesday's session: top gainers and losers ↗

May 27, 2026

Via Chartmill

Top stock movements in today's session. ↗

April 14, 2026

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Topics Artificial Intelligence

Most active stocks in Tuesday's session ↗

April 14, 2026

Get a pulse on the US markets on Tuesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.

Via Chartmill

Topics Artificial Intelligence

Emerging Now: ANY, GPRO, HOTH, SNAL Shift Strategic Focus in 2026

April 14, 2026

Via AB Newswire

Topics Artificial Intelligence Economy

Sphere 3D Corp.(NASDAQ: ANY) Transitions to AI Infrastructure Platform as Data Center Demand Surges

April 14, 2026

Via AB Newswire

Topics Artificial Intelligence Economy

Tuesday's session: gap up and gap down stocks ↗

April 14, 2026

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 14, 2026

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Via Chartmill

Top movers analysis one hour before the close of the markets on 2026-04-01: top gainers and losers in today's session. ↗

April 01, 2026

Via Chartmill

Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗

February 10, 2026

The company announced positive preclinical results from a study evaluating GDNF as a potential treatment for obesity and metabolic-associated steatotic liver disease.

Via Stocktwits

BioMedNewsBreaks — Lantern Pharma Inc. (NASDAQ: LTRN) Advancing Drug Discovery with PredictBBB.ai(TM) Partnership

October 22, 2025

Via Investor Brand Network

Topics Artificial Intelligence

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development

October 01, 2025

Via Investor Brand Network

Topics Artificial Intelligence

3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗

September 09, 2025

3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.

Via MarketBeat

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 02, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗

September 02, 2025

The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data

September 02, 2025

Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content

Via News Direct

Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data

September 02, 2025

Via AB Newswire

EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers ↗

September 02, 2025

Hoth Therapeutics reported strong preclinical efficacy and safety data for HT-KIT, a precision antisense therapy targeting KIT-driven cancers.

Via Benzinga

Top 5 Biotech Stocks With Strong Momentum ↗

August 28, 2025

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Via Benzinga

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 25, 2025

Via Get News

Topics Intellectual Property

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 25, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 25, 2025

Via Press Release Distribution Service

Topics Intellectual Property

The trading volume of these stocks is deviating from the norm in today's session. ↗

June 06, 2025

Unusual volume stocks in Friday's session

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 05, 2025

Via Benzinga

The trading volume of these stocks is deviating from the norm in today's session. ↗

June 05, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

What's going on in today's session ↗

June 04, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 04, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

June 04, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 17, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.